Literature DB >> 12948023

Interaction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison.

Gerben A Koning1, Henriëtte W M Morselt, Arko Gorter, Theresa M Allen, Samuel Zalipsky, Gerrit L Scherphof, Jan A A M Kamps.   

Abstract

PURPOSE: Evaluate the effectiveness of distal-end coupling of a tumor-specific antibody to liposomal polyethylene glycol (PEG) chains to improve target binding and reduce interference by macrophage uptake.
METHODS: Monoclonal antibody CC52, specific for CC531 rat colon carcinoma, was coupled to the bilayer of PEG-liposomes (type I) or to the distal end of bilayer-anchored PEG-chains (type II). Uptake of both (radiolabeled)liposome types by CC531 cells and rat liver macrophages was determined.
RESULTS: With increasing antibody density, both immunoliposome types showed increased binding to target cells, but type II liposomes displayed better target recognition than type I. Uptake by macrophages increased with antibody density for both liposome types. Lowest uptake by macrophages was found for type II liposomes at low antibody densities. Unexpectedly, not only for type I but also for type II liposomes, in which the antibody is coupled via its Fc moiety, uptake by macrophages was inhibited by aggregated IgG, indicating involvement of Fc receptors. Also polyinosinic acid, an inhibitor of scavenger receptors, reduced uptake of type II liposomes.
CONCLUSION: Although distal end coupling of antibodies to bilayer-anchored PEG chains in liposomes through the Fc moiety enhances target cell binding, it does not prevent the recognition by Fc receptors on macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948023     DOI: 10.1023/a:1025009300562

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.

Authors:  J A Harding; C M Engbers; M S Newman; N I Goldstein; S Zalipsky
Journal:  Biochim Biophys Acta       Date:  1997-07-25

2.  Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.

Authors:  J A Kamps; H W Morselt; P J Swart; D K Meijer; G L Scherphof
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro.

Authors:  J T Derksen; H W Morselt; D Kalicharan; C E Hulstaert; G L Scherphof
Journal:  Exp Cell Res       Date:  1987-01       Impact factor: 3.905

4.  Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.

Authors:  G A Koning; H W Morselt; M J Velinova; J Donga; A Gorter; T M Allen; S Zalipsky; J A Kamps; G L Scherphof
Journal:  Biochim Biophys Acta       Date:  1999-08-20

5.  Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes.

Authors:  S Zalipsky
Journal:  Bioconjug Chem       Date:  1993 Jul-Aug       Impact factor: 4.774

6.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.

Authors:  D C Litzinger; A M Buiting; N van Rooijen; L Huang
Journal:  Biochim Biophys Acta       Date:  1994-02-23

7.  Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.

Authors:  A Mori; S J Kennel; M van Borssum Waalkes; G L Scherphof; L Huang
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.

Authors:  K Maruyama; T Takizawa; T Yuda; S J Kennel; L Huang; M Iwatsuru
Journal:  Biochim Biophys Acta       Date:  1995-03-08

9.  Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures.

Authors:  C B Hansen; G Y Kao; E H Moase; S Zalipsky; T M Allen
Journal:  Biochim Biophys Acta       Date:  1995-11-01

10.  Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site.

Authors:  R L Marquet; D L Westbroek; J Jeekel
Journal:  Int J Cancer       Date:  1984-05-15       Impact factor: 7.396

View more
  11 in total

Review 1.  Dual targeting strategies with bispecific antibodies.

Authors:  Roland E Kontermann
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting.

Authors:  Melissa L Geddie; Neeraj Kohli; Dmitri B Kirpotin; Maja Razlog; Yang Jiao; Tad Kornaga; Rachel Rennard; Lihui Xu; Birgit Schoerberl; James D Marks; Daryl C Drummond; Alexey A Lugovskoy
Journal:  MAbs       Date:  2016-11-17       Impact factor: 5.857

3.  Fatty Acid Synthase (FASN) siRNA-Encapsulated-Her-2 Targeted Fab'-Immunoliposomes for Gene Silencing in Breast Cancer Cells.

Authors:  Arif Khan; Masood A Khan; Ahmed N Aljarbou; Yousef H Aldebasi; Khaled S Allemailem; Mohammed A Alsahli; Shamshir Khan; Abdulmohsen M Alruwetei
Journal:  Int J Nanomedicine       Date:  2020-08-05

4.  Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.

Authors:  Kathy Zhang; Melissa L Geddie; Neeraj Kohli; Tad Kornaga; Dmitri B Kirpotin; Yang Jiao; Rachel Rennard; Daryl C Drummond; Ulrik B Nielsen; Lihui Xu; Alexey A Lugovskoy
Journal:  MAbs       Date:  2015       Impact factor: 5.857

5.  Targeted liposomal drug delivery to monocytes and macrophages.

Authors:  Ciara Kelly; Caroline Jefferies; Sally-Ann Cryan
Journal:  J Drug Deliv       Date:  2010-10-26

6.  Characterization of different functionalized lipidic nanocapsules as potential drug carriers.

Authors:  Paola Sánchez-Moreno; Juan Luis Ortega-Vinuesa; Antonio Martín-Rodríguez; Houría Boulaiz; Juan Antonio Marchal-Corrales; José Manuel Peula-García
Journal:  Int J Mol Sci       Date:  2012-02-22       Impact factor: 6.208

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

Review 8.  Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.

Authors:  Rongrong Wang; Renzhong Xiao; Zhaowu Zeng; Lili Xu; Junjie Wang
Journal:  Int J Nanomedicine       Date:  2012-08-01

9.  Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.

Authors:  Mesha Saeed; Mandy van Brakel; Sara Zalba; Erik Schooten; Joost A P Rens; Gerben A Koning; Reno Debets; Timo L M Ten Hagen
Journal:  Int J Nanomedicine       Date:  2016-03-08

10.  Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.

Authors:  Dongyu Duan; Aiping Wang; Ling Ni; Liping Zhang; Xiuju Yan; Ying Jiang; Hongjie Mu; Zimei Wu; Kaoxiang Sun; Youxin Li
Journal:  Int J Nanomedicine       Date:  2018-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.